Knockdown of LINC00998 enables glioma cells to acquire high proliferation ability by regulating CBX3 and the c-Met/Akt/mTOR signaling pathway, which indicates that LINC00998 may provide a rationale for precision therapy in glioma patients. Here, MET is linked to central nervous system cancer.